Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/01/2007EP0783514B2 Sterol compositions from pulping soap
08/01/2007EP0695347B1 Methods and materials for treatment of individuals infected with intracellular infectious agents
08/01/2007EP0610511B2 Composition for dermatologic preparation
08/01/2007CN1330199C Radio base station, radio communication system, communication control method of cell station
08/01/2007CN1329519C Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process
08/01/2007CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
08/01/2007CN1329414C Bismuth potassium hyalurate and its preparation method and uses
08/01/2007CN1329409C Modulation of the expression of genes dependent on STAT-1
08/01/2007CN1329404C 6-2'-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral acticity
08/01/2007CN1329403C A process for preparing N-acylated lysophosphatidylcholine compounds and a pharmaceutical composition for treatment of metabolic bone disease comprising said compounds
08/01/2007CN1329400C Dicarba-closo-dodecaborane derivatives
08/01/2007CN1329398C Dihydroporphine E6 zinc compound photosensitizer and its preparation method and application
08/01/2007CN1329397C Cross-linked glycopeptide-cephalosporin antibiotics
08/01/2007CN1329396C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
08/01/2007CN1329395C Tricyclic imidazopyridines
08/01/2007CN1329394C Novel imidazole derivatives, production method thereof and use thereof
08/01/2007CN1329393C New purine derivatives
08/01/2007CN1329392C Substituted pyrazoles
08/01/2007CN1329389C Novel compounds and their use
08/01/2007CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors
08/01/2007CN1329386C Substituted phenylacetamides and their use as glucokinase activators
08/01/2007CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
08/01/2007CN1329379C Anaerobe resistant compound
08/01/2007CN1329378C Compounds useful to treat retroviral infections
08/01/2007CN1329376C Preparation method and medical uses of Nú¿1ú®-hydrocarbyl-3'-nitrotylindirubin derivative (I)
08/01/2007CN1329375C Novel anti-diabetic agents
08/01/2007CN1329374C Compound as CCR5 agonist
08/01/2007CN1329372C Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
08/01/2007CN1329359C Ether compounds, compositions, and uses thereof
08/01/2007CN1329072C Medicine for treating infant's fever and cough and preparing method
08/01/2007CN1329061C Medicating moxibustion musk bolus and its prepn
08/01/2007CN1329053C Externally applied agent for treating wean hives
08/01/2007CN1329039C Medicine for treating leukopenia and its preparing method
08/01/2007CN1329038C Water soluble nightshade extract, its preparation method and pharmaceutical compositions
08/01/2007CN1329037C Intravenous inject contg. pseudo-ginseng total saponin and its prodn. method
08/01/2007CN1329036C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
08/01/2007CN1329035C Method for preparing medicine composition contg. aspirin
08/01/2007CN1329034C Method for preventing/treating damage to sensory hair cells and cochlear neurons
08/01/2007CN1329033C Application of thiobiazole pyrimidine derivative in preparing antiviral medicine
08/01/2007CN1329032C Non-sedating barbiturate compounds as neuroprotective agents
08/01/2007CN1329031C Blood-fat regulating medicinal composition and use thereof
08/01/2007CN1329030C Inhibitor for liver cancer onset and progress
08/01/2007CN1329029C Painless injectable compositions containing salt of 2-arylpropionic acids
08/01/2007CN1329028C Ointment for quick curing trauma of burn and scald
08/01/2007CN1329027C Use of methyl aldehyde in preparation of medicines to preventing animals from toxic diseases
08/01/2007CN1329026C Pharmaceutical composition comprising (-)-secoisolariciresinol
08/01/2007CN1329025C Gels comprising at least one retinoid and benzoyl peroxide
08/01/2007CN1329024C Novel chromium (III) alpha amino acid complexes
08/01/2007CN1329023C HFA suspension formulations containing an anticholinergic
08/01/2007CN1329022C Hydrophilic biological sticking gel pasting agent and preparation technique thereof
08/01/2007CN1328979C Method for preparing milk-powder contg. micron sugared-ginseng, Luhouwang Xitiandou bee-glue for tonifying-Yin and nourishing-stomach
08/01/2007CN101010330A Partial and full agonists of A1 adenosine receptors
08/01/2007CN101010323A Bicyclononene derivatives as renin inhibitors
08/01/2007CN101010320A Aminotropane derivatives, preparation thereof and therapeutic use thereof
08/01/2007CN101010319A Indole derivatives, their manufacture and use as pharmaceutical agents
08/01/2007CN101010318A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010317A 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010316A Compounds useful for inhibiting CHK1
08/01/2007CN101010315A Substituted pyrazolyl urea derivatives useful in the treatment of cancer
08/01/2007CN101010314A Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
08/01/2007CN101010313A Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder
08/01/2007CN101010309A Oxopiperidine derivatives, preparation and therapeutic use thereof
08/01/2007CN101010304A Molecular chaperone function regulator
08/01/2007CN101010303A Quinazolinone derivatives and their use as B-RAF inhibitors
08/01/2007CN101010302A Sigma receptor inhibitors
08/01/2007CN101010301A 5-HT7 receptor antagonosts
08/01/2007CN101010300A 2-phenylpyridine derivative
08/01/2007CN101010299A Six-membered heterocycles useful as serine protease inhibitors
08/01/2007CN101010298A Histone deacetylase inhibitor prodrugs
08/01/2007CN101010297A N-(1h-indolyl)-1h-indole-2-carboxamide derivatives, their preparation and their therapeutic use
08/01/2007CN101010296A Piperazine derivatives of alkyhydroxy indole
08/01/2007CN101010295A Crystalline forms of 1,24(S)-dihydroxy vitamin D2
08/01/2007CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils
08/01/2007CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities
08/01/2007CN101010089A Tuberculosis treating and preventing agent
08/01/2007CN101010088A Compositions and methods of use for treatment of mammalian diseases
08/01/2007CN101010086A Ceramide derivatives as modulators of immunity and autoimmunity
08/01/2007CN101010085A Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
08/01/2007CN101010084A A composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
08/01/2007CN101010083A Methods and reagents for the treatment of metabolic disorders
08/01/2007CN101010082A Use of midostaurin for treating gastrointestinal stromal tumors
08/01/2007CN101010081A Mitochondria activators
08/01/2007CN101010080A Remedy for hyperlipemia
08/01/2007CN101010079A Remedy for glomerular diseae
08/01/2007CN101010078A Heterocyclic compounds as pharmaceutical agents
08/01/2007CN101010077A Use of targeted oxidative therapeutic formulation in treatment of burns
08/01/2007CN101010076A Immune function-improving agent
08/01/2007CN101010075A Materials and methods for improving shellfish health, immunity and growth
08/01/2007CN101010074A Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency
08/01/2007CN101010072A Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax
08/01/2007CN101010071A Method for producing a solid dosage form, which is safeguarded against abuse, while using a planetary gear extruder
08/01/2007CN101010070A Pharmaceutical composition
08/01/2007CN101010069A Compositions containing 5-amino-2-hydroxybenzoic acid and a reducing sugar
08/01/2007CN101010067A Modafinil oral lyophilizate
08/01/2007CN101010066A Stabilised prostaglandin composition
08/01/2007CN101007992A Health white spirit containing beneficial functional component
08/01/2007CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007839A Nucleic acid molecule RTN4BSR12 and its application in preparing anticancer medicine
08/01/2007CN101007838A Nucleic acid molecule RTN4BSR22 and its application in preparing anticancer medicine
1 ... 3647 3648 3649 3650 3651 3652 3653 3654 3655 3656 3657 3658 3659 3660 3661 3662 3663 3664 3665 3666 3667 ... 7860